Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Nifedipine

Kashif M. Khan  1 , Jayesh B. Patel  2 , Preeti Patel
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Nifedipine

Kashif M. Khan et al.
Free Books & Documents

Excerpt

Nifedipine is a dihydropyridine calcium channel blocker approved for the treatment of chronic stable angina and hypertension. This activity outlines the pharmacological profile of nifedipine, including indications, mechanism of action, routes of administration, and toxicity. Off-label uses are also reviewed to provide context for broader clinical applications. Attention is given to key drug-drug interactions, pharmacokinetics, and monitoring requirements to guide safe and effective prescribing. Significant adverse effects and contraindications are discussed to support risk assessment and therapeutic decision-making. Understanding these elements enables clinicians to tailor therapy to the patient's specific cardiovascular needs and comorbidities, thereby optimizing treatment outcomes.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Kashif Khan declares no relevant financial relationships with ineligible companies.

Disclosure: Jayesh Patel declares no relevant financial relationships with ineligible companies.

Disclosure: Preeti Patel declares no relevant financial relationships with ineligible companies.

References

    1. Sherman LG, Liang CS. Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial. Am J Cardiol. 1983 Mar 01;51(5):706-11. - PubMed
    1. Savonitto S, Ardissiono D, Egstrup K, Rasmussen K, Bae EA, Omland T, Schjelderup-Mathiesen PM, Marraccini P, Wahlqvist I, Merlini PA, Rehnqvist N. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol. 1996 Feb;27(2):311-6. - PubMed
    1. Dargie HJ, Lynch PG, Krikler DM, Harris L, Krikler S. Nifedipine and propranolol: a beneficial drug interaction. Am J Med. 1981 Oct;71(4):676-82. - PubMed
    1. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):1269-1324. - PubMed
    1. Shekhar S, Gupta N, Kirubakaran R, Pareek P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG. 2016 Jan;123(1):40-7. - PubMed

Publication types

LinkOut - more resources